Mawson Infrastructure Group Inc. — Director's Dealing 2019

Dec 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-12-20

Reporting Person: Rubini Jonathan Brian (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-20	Common Stock	P	2037037	$0.27	Acquired	2455739	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-20	Warrants	$0.27	P	4074047	Acquired	2024-12-19	Common Stock (4074047)	Direct

Footnotes

F1: Exercisable five days following the public announcement of positive clinical data results for LO2A